Paclitaxel and Carboplatin vs Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
J. Clin. Oncol 2022 Jan 10;[EPub Ahead of Print], MA Powell, VL Filiaci, ML Hensley, HQ Huang, KN Moore, KS Tewari, LJ Copeland, AA Secord, DG Mutch, A Santin, DP Warshal, NM Spirtos, PA DiSilvestro, OB Ioffe, DS MillerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.